TITLE

A love story

AUTHOR(S)
Plamondon, Stephanie
PUB. DATE
January 2002
SOURCE
CMAJ: Canadian Medical Association Journal;1/22/2002, Vol. 166 Issue 2, p222
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents the story of a patient with amyotrophic lateral sclerosis (ALS) who decided not to use artificial ventilation during the night. Relationship between a husband and his wife, who had ALS; Reaction of the student doctor on observing the decision of the ALS patient and her husband.
ACCESSION #
5955275

 

Related Articles

  • Discussing sexuality with patients in a motor neurone disease clinic. Marsden, Rachael; Botell, Rachel // Nursing Standard;12/15/2010, Vol. 25 Issue 15-17, p40 

    Sexual relationships remain an important aspect of life for people living with motor neurone disease. This article explores the use of the Extended-PLISSIT model when discussing relationships and sexual function with patients and their partners in a motor neurone disease clinic. The model...

  • Self-Reported Quality of Life in Amyotrophic Lateral Sclerosis. Nygren, Ingela; Askmark, Håkan // Journal of Palliative Medicine;Apr2006, Vol. 9 Issue 2, p304 

    Objectives: To continuously assess overall quality of life (QOL) and disease progression in patients with amyotrophic lateral sclerosis (ALS) at different stages of the disease and compare the results between these two variables. Design/subjects: Twenty-six patients with ALS were interviewed...

  • Patients with amyotrophic lateral sclerosis and cancer do not differ clinically from patients with sporadic amyotrophic lateral sclerosis. Vigliani, Maria Claudia; Polo, Patrizia; Chió, Adriano; Giometto, Bruno; Mazzini, Letizia; Schiffer, Davide // Journal of Neurology;Oct2000, Vol. 247 Issue 10, p778 

    We examined whether patients with both amyotrophic lateral sclerosis (ALS) and cancer differ from classical ALS patients, and whether motor neuron disease responds to oncological therapy. We analyzed clinical and immunological features of 14 patients (9 men, 5 women; mean age 65.3 years) with...

  • Biochemical Markers in CSF of ALS Patients. Süssmuth, Sigurd D.; Brettschneider, Johannes; Ludolph, Albert C.; Tumani, Hayrettin // Current Medicinal Chemistry;2008, Vol. 15 Issue 18, p1788 

    Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron diseases (MND) characterized by progressive selective degeneration of motor neurons. Although several mutations underlying rare cases of familial ALS were identified during the last decade, the pathogenesis of ALS...

  • A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. Saccà, Francesco; Quarantelli, Mario; Rinaldi, Carlo; Tucci, Tecla; Piro, Raffaele; Perrotta, Gaetano; Carotenuto, Barbara; Marsili, Angela; Palma, Vincenzo; Michele, Giuseppe; Brunetti, Arturo; Brescia Morra, Vincenzo; Filla, Alessandro; Salvatore, Marco // Journal of Neurology;Jan2012, Vol. 259 Issue 1, p132 

    Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease with motor neuron degeneration. Riluzole is the only available treatment. Two-thirds of ALS patients present with growth hormone (GH) deficiency. The aim of this study is to determine if add-on of GH to riluzole, with an...

  • An Association Study of Riluzole Serum Concentration and Survival and Disease Progression in Patients With ALS. Groeneveld, G. J.; van Kan, H. J. M.; Lie-A-Huen, L.; Guchelaar, H.-J.; van den Berg, L. H. // Clinical Pharmacology & Therapeutics;May2008, Vol. 83 Issue 5, p718 

    Patients with amyotrophic lateral sclerosis (ALS) who are treated with the antiglutamatergic drug riluzole receive a fixed-dose regimen of 50 mg b.i.d. The drug has been shown to increase tracheostomy-free survival by 3–6 months. The pharmacokinetics of riluzole show a high...

  • Is Taste Altered in Patients with ALS? Pelletier, Cathy; Abou-Zeid, Elias; Bartoshuk, Linda; Rudnicki, Stacy // Chemosensory Perception;Jun2013, Vol. 6 Issue 2, p101 

    Amyotrophic lateral sclerosis (ALS) is a degenerative neurological disease that affects the motor systems in patients but also may affect some sensory systems. Some ALS patients report taste changes that may decrease their oral intake and nutritional status. This study examined whether focal...

  • FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD. Orozco, Denise; Edbauer, Dieter // Journal of Molecular Medicine;Dec2013, Vol. 91 Issue 12, p1343 

    Mutations in fused in sarcoma (FUS) in a subset of patients with amyotrophic lateral sclerosis (ALS) linked this DNA/RNA-binding protein to neurodegeneration. Most of the mutations disrupt the nuclear localization signal which strongly suggests a loss-of-function pathomechanism, supported by...

  • Linear Associations between Clinically Assessed Upper Motor Neuron Disease and Diffusion Tensor Imaging Metrics in Amyotrophic Lateral Sclerosis. Woo, John H.; Wang, Sumei; Melhem, Elias R.; Gee, James C.; Cucchiara, Andrew; McCluskey, Leo; Elman, Lauren // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Objective: To assess the relationship between clinically assessed Upper Motor Neuron (UMN) disease in Amyotrophic Lateral Sclerosis (ALS) and local diffusion alterations measured in the brain corticospinal tract (CST) by a tractography-driven template-space region-of-interest (ROI) analysis of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics